Co-Founder and Chief Technology Officer
Qi Biodesign
Kevin Zhao is a co-founder and Chief Technology Officer of Qi Biodesign, a company dedicated to the advancement of precision genome editing in new crop breeding. He graduated with his PhD from Harvard University in the lab of David Liu where he developed a rapid and continuous protein directed evolution system and used this method to develop new and efficient base editors. Since starting Qi Biodesign with Caixia Gao in 2021, he has published studies in Cell and Nature Biotechnology as a co-corresponding author. Kevin was selected to be on Forbes 30 Under 30 Asia Pacific and MIT Technology Review Innovators Under 35 Asia lists.